BONH
UTHR icon

Bank of New Hampshire’s United Therapeutics UTHR Stock Holding History

Bank of New Hampshire’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
526
+64
+14% +$36K 0.06% 181
2026
Q1 		$274K Buy
+462
New +$230K 0.06% 178
2025
Q1 		– Sell
-35
Closed -$12.3K – 471
2024
Q4 		$12.3K Hold
35
– – ﹤0.01% 385
2024
Q3 		$12.5K Hold
35
– – ﹤0.01% 387
2024
Q2 		$11.1K Hold
35
– – ﹤0.01% 410
2024
Q1 		$8.04K Hold
35
– – ﹤0.01% 429
2023
Q4 		$7.7K Hold
35
– – ﹤0.01% 429
2023
Q3 		$7.91K Hold
35
– – ﹤0.01% 425
2023
Q2 		$7.73K Buy
+35
New +$7.75K ﹤0.01% 440

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bank of New Hampshire's UTHR Position: Q2 2026 in Review

Bank of New Hampshire increased its United Therapeutics (UTHR) stake by 14% in Q2 2026, buying an estimated $36K and bringing the position to 526 shares worth $285K. The position accounts for 0.06% of the portfolio, ranked #181.

Bank of New Hampshire first reported a position in UTHR in Q2 2023 and has held it in 9 quarters since. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Bank of New Hampshire held 526 shares of United Therapeutics worth $285K as of Q2 2026.
  • Bank of New Hampshire bought 64 United Therapeutics shares in Q2 2026, an estimated $36K.
  • United Therapeutics made up 0.06% of Bank of New Hampshire's portfolio in Q2 2026, its #181 holding.
  • Bank of New Hampshire first reported a position in United Therapeutics in Q2 2023 and has held it in 9 quarters since.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.